XEL
58
-4
DIS
50
-2
FSLR
57
8
GPC
22
-3
VTR
46
-3
PPL
52
-7
MDT
62
3
ESS
47
-4
VZ
34
-3
AMZN
56
5
NUE
50
2
PNW
60
-6
NKE
30
2
YUM
38
2
NTRS
49
-3
LH
40
-2
AEE
50
-3
USB
46
-2
D
38
-2
INTU
47
4
XEL
58
-4
DIS
50
-2
FSLR
57
8
GPC
22
-3
VTR
46
-3
PPL
52
-7
MDT
62
3
ESS
47
-4
VZ
34
-3
AMZN
56
5
NUE
50
2
PNW
60
-6
NKE
30
2
YUM
38
2
NTRS
49
-3
LH
40
-2
AEE
50
-3
USB
46
-2
D
38
-2
INTU
47
4
Financhill
Back

Emergent BioSolutions Quote, Financials, Valuation and Earnings

The TRUTH About Dividend Stocks

Free workshop shows the 3-step process anyone can use to build Ultimate Dividend Portfolio
Sell
40

EBS
Emergent BioSolutions

Last Price:
9.14
Seasonality Move:
6.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Investing Today: The Best Way To Grow A Small Account

In his free guide, expert Joe Duffy reveals... click here to read on...

Emergent BioSolutions Price Quote

$9.14
+0.02 (+0.88%)
(Updated: November 2, 2024 at 6:20 AM ET)

Emergent BioSolutions Key Stats

Sell
40
Emergent BioSolutions (EBS) is a Sell
Day range:
$8.98 - $9.42
52-week range:
$1.42 - $15.10
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.44
P/B ratio:
1.25%
Volume:
1M
Avg. volume:
1.7M
1-year change:
365.31%
Market cap:
$483.3M
Revenue:
$1B
EPS:
$-11.24

How Much Does Emergent BioSolutions Make?

Is Emergent BioSolutions Growing As A Company?

  • What Is Emergent BioSolutions's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.25%
  • What Is Emergent BioSolutions's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Emergent BioSolutions Stock Price Performance

What Is Emergent BioSolutions 52-Week High & Low?

Emergent BioSolutions Price To Free Cash Flow

Is It Risky To Buy Emergent BioSolutions?

Is Emergent BioSolutions Cash Flow Positive?

  • What Is EBS Cash Flow From Operations?
    Cash flow from operations (TTM) is $77M
  • What Is Emergent BioSolutions’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$48.5M
  • What Is Emergent BioSolutions’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$45.7M

Emergent BioSolutions Return On Invested Capital

  • Is Management Doing A Good Job?
    EBS return on invested capital is -37.89%
  • What Is Emergent BioSolutions Return On Assets?
    ROA measures how assets are converting to revenues and is -31.86%
  • What Is EBS Return On Equity?
    ROE is a measure of profitability and is -87.53%

Emergent BioSolutions Earnings Date & Stock Price

Emergent BioSolutions Competitors

Emergent BioSolutions Dividend Yield

Emergent BioSolutions Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: -25.11% 34.05%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 8.00
Downside from Last Price: -12.28%

Major Shareholders

  • How many EBS shares are owned by institutional investors?
    42.7M EBS shares are owned by institutional investors
  • How many EBS shares are owned by insiders?
    3.9M EBS shares are owned by insiders